Table 2.
Univariate analysis investigating potential risk factors of 30-DM.
| OR | CI 95% | p value | |
|---|---|---|---|
| Age | 0.8460 | ||
| 18–64 years | 1 | 1 | |
| ≥ 65 years | 1.001 | (0.987; 1.016) | |
| Sex | 0.0001 | ||
| Female | 1 | ||
| Male | 2.37 | (1.5.; 3.66) | |
| ECOG PS | <0.0001 | ||
| ECOG PS 0–1 | 1 | ||
| ECOG PS 2–3 | 4.22 | (2.78; 6.40) | |
| Primary tumor | |||
| Breast | 1 | ||
| Lung | 1.66 | (1.11; 2.48) | 0.0133 |
| Prostate | 0.79 | (0.41; 1.50) | 0.4665 |
| Gastrointestinal | 1.7 | (1.04; 2.78) | 0.0358 |
| Urinary tract | 1.04 | (0.55; 1.97) | 0.8985 |
| Gynecologic | 0,367 | (0,111; 1,208) | 0,0990 |
| Head and neck | 1.01 | (0.41; 2.49) | 0.9833 |
| Other | 1.01 | (0.48; 2.13) | 0.9793 |
| Visceral Metastases | |||
| Absent | 1 | ||
| Present | 1.55 | (1.03; 2.33) | 0.0362 |
| Location of the treatment | 0.6517 | ||
| Primary tumor | 1 | ||
| Bone | 0.90 | (0.44; 1.71) | |
| Brain | 0.73 | (0.36; 1.49) | |
| Lymph nodes | 0.25 | (0.003; 2.05) | |
| Soft tissue | 0.91 | (0.35; 2.40) |
Bold values: statistically significant.